Operating expenses
The latest news about Operating expenses: headlines, AI summaries and the full story from every source.
- Kardigan, Inc. Reports Q3 GAAP EPS of -$0.64, Exceeding Analyst Expectations
- Anterix Reports Q2 2026 Revenue Growth Amid Strategic Spectrum Monetization
- Worksport Reports Record Q3 Revenue and Outlines Future Product Milestones
- Bionano Genomics Reports Q3 2026 Revenue Growth Driven by Consumables and Instrument Sales
- QT Imaging Reports 75% Revenue Growth in Q3 2026 Amidst Middle East Logistics Disruptions
- Seer Inc Reports Q3 2026 Revenue of $4.0 Million Amid Lowered Full-Year Guidance
- Dundee Preference Shares Series 3 Reports Q3 2026 GAAP EPS of $0.53
- Achieve Life Sciences Reports Q3 Financial Results with $12.1 Million Net Loss
- NexGen Energy Reports Narrower Q3 Net Loss Amid Rook I Project Progress
- AlTi Global Reports Q3 2026 Results with Reduced Expenses and New $85 Million Credit Facility
- OraSure Technologies Projects Q4 Revenue Between $30M-$32M Amid Return to Growth
- Medicus Pharma Reports Q3 2026 Financial Results and Strategic Shift Toward Precision Oncology
- H&R Block Reports Q1 Earnings Beat on Revenue and Non-GAAP EPS
- Lucid Group Faces Investor Scrutiny Over Cash Flow Improvements and Cosmos Program Progress
- MVB Financial Reports Q3 2026 Earnings with Margin Expansion and Fintech Deposit Growth
- Universal Electronics Inc. (UEIC) Reports Q3 2026 Results with Improved EPS Amid Revenue Decline
- Sera Prognostics Reports 163% Year-Over-Year Revenue Growth in Q3 2026
- CVRx Reports Q3 2026 Revenue Decline Amid Reimbursement Headwinds
- Playboy Exceeds Q3 Earnings Estimates Amid Core Business Growth
- 3D Systems Projects Q4 Revenue Between $100M and $103M with Near-Breakeven EBITDA
- IN8bio Reports Third Quarter Financial Results
- Elicio Therapeutics Reports Narrowed Net Loss for Third Quarter
- Network-1 Technologies Reports Q3 2026 Net Loss of $2.33 Million
- Inogen Reports Q3 2026 Results with Revenue Decline Amid International Market Softness
- Karat Packaging Reports Q3 2026 Results with Revenue Growth Amid Margin Pressure
- Global Water (GWRS) Reports Q3 2026 Revenue Growth Amid Declining Net Income
- Quantum-Si Reports Q3 Earnings with EPS Beat and Revenue Miss
- Serve Robotics Reports Strong Q3 Results and Raises Full-Year Revenue Guidance
- Duolingo Reports Strong Third Quarter User Growth and Reduced AI Costs
- Wolfe Research Upgrades MSG Knickerbockers to Outperform
- NexPoint Residential Reports Q3 2026 Earnings Miss and Lowers Full-Year Guidance
- JetBlue Increases Checked Bag Fees to Offset Rising Fuel Costs
- Fusemachines Reports Q3 Revenue of $1.85 Million and Improved Adjusted EBITDA
- Tactile Systems Technology Q3 Revenue Grows 7% Amid Rising Expenses and Airway Clearance Slump
- Vertex Pharmaceuticals Reports 12% Revenue Growth Driven by Alyftrek Transition
- CarParts.com Reports Q3 2026 Revenue Growth and Third Consecutive Quarter of Positive Adjusted EBITDA
- Ryanair Net Profit Drops 15% Amid Rising Fuel Costs Despite Share Buyback and Dividend Plans
- Kansas City Life Reports Third Quarter 2026 Net Income of $1.7 Million
- Atomera Reports Zero Revenue for Q3 2026 Amid Rising Operating Expenses
- Community Health Systems Reports Q3 2026 Net Loss Amid Hospital Divestitures and Uninsured Patient Growth
- Advantex Marketing International Reports Annual Revenue of $5.75 Million
- Vanda Pharmaceuticals Projects 2026 Revenues Exceeding $240 Million Following Q3 Growth
- Beta Bionics Reports Q3 2026 Revenue Growth Driven by Pharmacy Channel Expansion
- Invesco Projects EPS Growth Driven by Preferred Buybacks and Debt Repayment
- Pharming Reports Q3 Revenue Growth of 20.9% and Updates 2026 Guidance
- Byrna Reports Q3 Earnings with Revenue Drop but Improved Margins
- D-Wave Quantum's Flat Revenue Amid Rising Costs Raises Concerns
- Innate Pharma Reports Q2 2026 Financial Results and Strategic Updates
- Jefferson Capital Reports Strong Growth Amid Rising Costs
- Geron Forecasts RYTELO Revenue Near High End of Guidance as Community Use Grows